Hagop Kantarjian, MD, Honored by ASCO for Leukemia Research

Kantarjian receives the highest honor from the American Society of Clinical Oncology (ASCO) for his lifelong contributions to leukemia research and patient care.

Related Keywords

United States ,Chicago ,Illinois ,Texas ,Lebanon ,American ,America ,Lebanese ,Kenneth Mccredie ,Michael Keating ,Davida Karnofsky ,Hagop Kantarjian ,Emil Freireich ,Department Of Leukemia ,American University Of Beirut ,American Lebanese Medical Association Lifetime Achievement Award ,Society Of Hematologic Oncology ,Rice Baker Institute ,University Of Texas Md Anderson Cancer Center ,American Society Of Clinical Oncology ,Leukemia Society Of America Special ,Samsung Distinguished University ,Memorial Award ,American Society ,Clinical Oncology ,Medscape Medical ,Samsung Distinguished University Chair ,Cancer Medicine ,American University ,Leukemia Outcomes ,Hematologic Oncology ,Leukemia Fellowship ,American Lebanese Medical Association ,Lifetime Achievement Award ,American Association ,Cancer Research ,Leukemia Society ,Outstanding Service ,America Special Fellow ,Acute Leukemia ,Leukemia ,Myelodysplastic Syndrome ,Ads ,Acute Lymphoblastic Leukemia ,Acute Myeloblastic Leukemia ,Chronic Myelogenous Leukemia ,Cancer ,Alignant Neoplasia ,Arcinoma ,Biologic Therapy ,Antineoplastic Drug ,Nti Cancer Agents ,Evacizumab ,Rlotinib ,Efitinib ,Matinib ,Ituximab ,U11248 ,Unitinib ,Rastuzumab ,Targeted Therapy ,Genomics ,Genomic Medicine ,Edicine Genomic ,Toxicology ,